0001062993-23-022793.txt : 20231218 0001062993-23-022793.hdr.sgml : 20231218 20231218200425 ACCESSION NUMBER: 0001062993-23-022793 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231218 FILED AS OF DATE: 20231218 DATE AS OF CHANGE: 20231218 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: McWherter Charles CENTRAL INDEX KEY: 0001588862 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36500 FILM NUMBER: 231495316 MAIL ADDRESS: STREET 1: C/O CYMABAY THERAPEUTICS, INC. STREET 2: 7575 GATEWAY BLVD., SUITE 110 CITY: NEWARK STATE: CA ZIP: 94560 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CymaBay Therapeutics, Inc. CENTRAL INDEX KEY: 0001042074 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 943103561 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7575 GATEWAY BOULEVARD STREET 2: SUITE 110 CITY: NEWARK STATE: CA ZIP: 94560 BUSINESS PHONE: 510-293-8800 MAIL ADDRESS: STREET 1: 7575 GATEWAY BOULEVARD STREET 2: SUITE 110 CITY: NEWARK STATE: CA ZIP: 94560 FORMER COMPANY: FORMER CONFORMED NAME: METABOLEX, INC. DATE OF NAME CHANGE: 20090721 FORMER COMPANY: FORMER CONFORMED NAME: METABOLEX INC DATE OF NAME CHANGE: 19970710 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0508 4 2023-12-18 0001042074 CymaBay Therapeutics, Inc. CBAY 0001588862 McWherter Charles C/O CYMABAY THERAPEUTICS, INC. 7575 GATEWAY BLVD., SUITE 110 NEWARK CA 94560 0 1 0 0 President of R&D 0 Common Stock 2023-12-18 4 M 0 4828 5.00 A 19828 D Common Stock 2023-12-18 4 S 0 4828 21.4867 D 15000 D Common Stock 2023-12-18 4 M 0 6504 5.00 A 21504 D Common Stock 2023-12-18 4 S 0 6504 21.4796 D 15000 D Employee Stock Option (right to buy) 5.00 2023-12-18 4 M 0 704 0 D 2023-12-22 Common Stock 704 0 D Employee Stock Option (right to buy) 5.00 2023-12-18 4 M 0 234 0 D 2023-12-22 Common Stock 234 0 D Employee Stock Option (right to buy) 5.00 2023-12-18 4 M 0 3890 0 D 2023-12-22 Common Stock 3890 0 D Employee Stock Option (right to buy) 5.00 2023-12-18 4 M 0 6504 0 D 2024-01-05 Common Stock 6504 0 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on February 24, 2023. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.00 to $21.80, inclusive. The reporting person undertakes to provide to CymaBay Therapeutics, Inc., any security holder of CymaBay Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The original option vested as to 1/4 of the underlying shares on July 23, 2008 and the remaining 3/4 of the underlying shares vested ratably on a monthly basis over the 36 months thereafter. The original option vested as to 1/48 of the underlying shares monthly from October 15, 2009. The option vested in full on December 23, 2015. The option vested as to 1/3 of the underlying shares on January 6, 2014 and the remaining 2/3 of the underlying shares vested ratably on a monthly basis over the 48 months thereafter. /s/ Paul Quinlan, as attorney-in-fact for Charles McWherter 2023-12-18